Thursday, 26 April 2018 - 6:34
  • it
  • de
  • en
  • fr

SIFI

Sifi reaches Asia: Mini Well Ready approved in South Corea

Italy-based pharmaceutical group Sifi, focusing on developing and marketing solutions for eye diseases, today announced that the South-Corean authorities have approved the Mini Well Ready intraocular lens. Mini Well Ready is a progressive intraocular lens with extended depth of focus,…

AIFA grants reimbursement to SIFI’s Iluvien

SIFI announced that Iluvien (fluocinolone acetonide), a product for the treatment of Diabetic Macular Edema, has been granted reimbursement by the Italian Medicines Agency (AIFA). SIFI exclusively markets Iluvien in Italy, San Marino and Vatican City under license from Alimera…

SIFI to license part of its product portfolio to Polifarma

SIFI and Polifarma announced today a license agreement under which Polifarma will deal in Italy the following ophthalmic products included in SIFI’s portfolio: Carteol, Colbiocin unguento, Genticol, Pensulvit, Mirtilene Forte, Lubristil and Epinerve. According to the agreement terms, Polifarma will…